JP2017523810A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523810A5
JP2017523810A5 JP2017526770A JP2017526770A JP2017523810A5 JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5 JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017526770 A JP2017526770 A JP 2017526770A JP 2017523810 A5 JP2017523810 A5 JP 2017523810A5
Authority
JP
Japan
Prior art keywords
seq
sequence
dna
mutant allele
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017526770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523810A (ja
JP6770957B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GR2015/000036 external-priority patent/WO2016020710A1/en
Publication of JP2017523810A publication Critical patent/JP2017523810A/ja
Publication of JP2017523810A5 publication Critical patent/JP2017523810A5/ja
Application granted granted Critical
Publication of JP6770957B2 publication Critical patent/JP6770957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017526770A 2014-08-07 2015-07-28 試料中のpik3ca突然変異状態を決定する方法 Active JP6770957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034231P 2014-08-07 2014-08-07
US62/034,231 2014-08-07
PCT/GR2015/000036 WO2016020710A1 (en) 2014-08-07 2015-07-28 Method of determining pik3ca mutational status in a sample

Publications (3)

Publication Number Publication Date
JP2017523810A JP2017523810A (ja) 2017-08-24
JP2017523810A5 true JP2017523810A5 (show.php) 2018-06-21
JP6770957B2 JP6770957B2 (ja) 2020-10-21

Family

ID=53938365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017526770A Active JP6770957B2 (ja) 2014-08-07 2015-07-28 試料中のpik3ca突然変異状態を決定する方法

Country Status (18)

Country Link
US (1) US11279979B2 (show.php)
EP (1) EP3198026B1 (show.php)
JP (1) JP6770957B2 (show.php)
CN (1) CN106715723B (show.php)
CA (1) CA2957396C (show.php)
CY (1) CY1122647T1 (show.php)
DK (1) DK3198026T3 (show.php)
ES (1) ES2764423T3 (show.php)
HR (1) HRP20192353T1 (show.php)
HU (1) HUE047958T2 (show.php)
IL (1) IL250392B (show.php)
LT (1) LT3198026T (show.php)
PL (1) PL3198026T3 (show.php)
PT (1) PT3198026T (show.php)
RS (1) RS59710B1 (show.php)
SI (1) SI3198026T1 (show.php)
SM (1) SMT202000005T1 (show.php)
WO (1) WO2016020710A1 (show.php)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9115402B2 (en) 2010-05-14 2015-08-25 Dana-Farber Cancer Institute, Inc. Compositions and methods of identifying tumor specific neoantigens
US11051814B2 (en) 2013-09-16 2021-07-06 Oregon Health & Science University Bioabsorbable clips and applicator for tissue closure
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
JP7060324B2 (ja) 2013-12-20 2022-04-26 ザ・ブロード・インスティテュート・インコーポレイテッド ネオ抗原ワクチンによる併用療法
CA2965986C (en) 2014-11-03 2019-05-07 Oregon Health & Science University Clips and applicator for tissue closure
EP3234193B1 (en) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molecular biomarkers for cancer immunotherapy
ES3049406T3 (en) 2014-12-19 2025-12-16 Broad Inst Inc Methods for profiling the t-cell-receptor repertoire
CR20230191A (es) 2015-05-20 2023-07-06 Dana Farber Cancer Inst Inc NEOANTIGENOS COMPARTIDOS (Div. exp 2017-584)
US10870891B2 (en) 2017-01-05 2020-12-22 Biodesix, Inc. Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
EP3574116A1 (en) 2017-01-24 2019-12-04 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
CA3058807A1 (en) 2017-04-03 2018-10-11 Neon Therapeutics, Inc. Protein antigens and uses thereof
CN107287309A (zh) * 2017-07-06 2017-10-24 罗保君 一种血液循环肿瘤dna点突变检测方法
CN110869516A (zh) * 2017-07-26 2020-03-06 积水医疗株式会社 检测突变基因的方法
CN109295175A (zh) * 2017-09-08 2019-02-01 广州健天基因技术有限公司 用于检测人胃肠道间质瘤c-kit基因v559a突变的引物、检测方法及试剂盒
CN109306374A (zh) * 2017-09-08 2019-02-05 广州健天基因技术有限公司 用于检测人类pik3ca基因e545k突变的引物、检测方法及试剂盒
JP7306618B2 (ja) * 2017-09-26 2023-07-11 東ソー株式会社 がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
CN107937490A (zh) * 2018-01-15 2018-04-20 福建农林大学 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒
WO2019155050A1 (en) * 2018-02-12 2019-08-15 F. Hoffmann-La Roche Ag Method of predicting response to therapy by assessing tumor genetic heterogeneity
BR112020025764A2 (pt) 2018-06-19 2021-05-11 Biontech Us Inc. neoantígenos e usos dos mesmos
CN109666747A (zh) * 2019-02-20 2019-04-23 天津脉络医学检验有限公司 一种引物探针组合物及其应用
US11812966B2 (en) 2020-04-24 2023-11-14 NeuraMedica Inc. Clips, appliers, and cartridges
KR20230006852A (ko) * 2020-05-01 2023-01-11 윌리엄 마쉬 라이스 유니버시티 무보정 및 다중 변이체 대립유전자 빈도 정량화를 위한 정량적 블로커 변위 증폭(qbda) 시퀀싱
CN113930500B (zh) * 2020-07-13 2024-11-19 铭炽生物科技(上海)有限公司 人pik3ca基因突变的数字pcr检测方法及应用
CN112951325B (zh) * 2021-02-18 2023-04-21 北京吉因加医学检验实验室有限公司 一种用于癌症检测的探针组合的设计方法及其应用
CN113063835B (zh) * 2021-03-19 2022-08-02 中山大学 一种基于元素标记-电感耦合等离子体质谱检测策略的cfDNA分析方法及其应用
US20250092445A1 (en) * 2021-08-25 2025-03-20 Manjing Genscript Biotech Co., Ltd. Primer set and gene chip method for detecting single base mutation
US12531162B1 (en) * 2023-05-31 2026-01-20 Northeastern University Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE045690T2 (hu) 2004-03-02 2020-01-28 Univ Johns Hopkins A PIK3CA gén mutációi humán rákokban
EP2129791A4 (en) * 2007-02-26 2010-07-28 Wayne John Cancer Inst BENEFITS OF THE B-RAF DNA MUTATION FOR THE DIAGNOSIS AND TREATMENT OF CANCER
US8071338B2 (en) * 2007-08-08 2011-12-06 Roche Molecular Systems, Inc. Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5′-3′ nuclease activity
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
US20100041048A1 (en) * 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
CN101445832B (zh) 2008-12-23 2011-09-14 广州益善生物技术有限公司 Pik3ca基因突变的检测探针、液相芯片及其检测方法
CN102234685B (zh) * 2010-04-23 2014-08-27 益善生物技术股份有限公司 一种pik3ca基因突变检测液相芯片
EP2646576B1 (en) 2010-12-03 2015-10-28 Brandeis University Methods and kits for detecting nucleic acid mutants in wild-type populations
CN102533958A (zh) 2010-12-28 2012-07-04 苏州科贝生物技术有限公司 一种检测人pik3ca基因突变的方法和试剂盒
EP2663652B1 (en) 2011-01-11 2018-11-14 Roche Diagniostics GmbH High resolution melting analysis as a prescreening tool
WO2012131092A2 (en) * 2011-03-31 2012-10-04 Signature Diagnostics Ag Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages
EP3382039B1 (en) * 2011-05-04 2023-09-13 Biocept, Inc. Methods for detecting nucleic acid sequence variants
CN103906848B (zh) * 2011-08-18 2016-03-02 雀巢产品技术援助有限公司 用于检测等位变体的组合物和方法
JP2013081450A (ja) 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
EP2711432A1 (en) 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
EP3666903B1 (en) * 2013-08-12 2025-12-31 Bio-Rad Laboratories, Inc. AMPLIFICATION REPORTER GENE CONTAINING OLIGOMERS WITH BASIC PAIRINGS

Similar Documents

Publication Publication Date Title
JP2017523810A5 (show.php)
HRP20192353T1 (hr) Metoda određivanja mutacijskog statusa pik3ca u uzorku
US12270081B2 (en) Method for quantification of PD-L1 expression
Ng et al. Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study
ES2577289T3 (es) Calreticulina mutante para el diagnóstico de malignidades mieloides
Cabanero et al. Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer
JP2019518437A (ja) 多重/最適化ミスマッチ増幅(moma)−がんの評価のためのリアルタイムpcr
Gonzalez-Bosquet et al. Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers
JP7085235B2 (ja) 膵がん診断キット
Jin et al. Rapid and accurate detection of KRAS mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics
Zeng et al. Detection of PIK3CA mutations in plasma DNA of colorectal cancer patients by an ultra-sensitive PNA-mediated PCR
Tabone et al. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study
JP2016510982A5 (show.php)
JP2015500638A5 (show.php)
JP2020019738A (ja) がんの診断のためのプローブ/プライマーライブラリー
KR20110042511A (ko) PNA 기반의 실시간 PCR 클램핑을 이용한 K-ras 돌연변이 검출 방법 및 키트
KR102600344B1 (ko) Kras 유전자 돌연변이 검출용 조성물 및 이를 포함하는 키트
Feuillie et al. Detection of DNA sequences refractory to PCR amplification using a biophysical SERRS assay (Surface Enhanced Resonant Raman Spectroscopy)
US12391985B2 (en) Method of determining PIK3CA mutational status in a sample
JP2014535050A5 (show.php)
RU2440415C1 (ru) Набор синтетических олигонуклеотидов для определения нуклеотидной последовательности кодирующей части гена brca1 и выявления мутаций, ассоциированных с наследственными формами рака молочной железы
WO2014078571A1 (en) Methods of detecting 14q32 translocations
JP6346493B2 (ja) ペプチドワクチン療法の効果予測方法
JP2015177745A (ja) 肺癌の検査方法
US20170204463A1 (en) Method for predicting risk of ankylosing spondylitis using dna copy number variants